Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alternative processing events in human FMO genes.

Virginie Lattard1, Jun Zhang, John R Cashman

  • 1Human BioMolecular Research Institute, San Diego, California, USA.

Molecular Pharmacology
|May 25, 2004
PubMed
Summary

Human flavin-containing monooxygenase (FMO) gene expression includes numerous splice variants. Most FMO splice variants lack functional enzyme activity, including common exon-deleted forms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibody-Assisted Protection from Paraoxon and Nerve Agent Model Compounds.

Journal of medicinal chemistry·2026
Same author

Immunotherapeutic Protection From a Soman Nerve Agent Model Compound.

Journal of biochemical and molecular toxicology·2025
Same author

Practical Aspects of Flavin-Containing Monooxygenase-Mediated Metabolism.

Chemical research in toxicology·2024
Same author

Effect of PAWI-2 on pancreatic cancer stem cell tumors.

Investigational new drugs·2024
Same author

Human-induced pluripotent stem cell-derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs.

Pharmacology research & perspectives·2021
Same author

Human iPSC-derived cardiomyocytes and pyridyl-phenyl mexiletine analogs.

Bioorganic & medicinal chemistry letters·2021

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Flavin-containing monooxygenases (FMOs) are crucial enzymes in human drug metabolism and detoxification.
  • Functional diversity of FMOs is influenced by the expression of five FMO genes (FMO1-FMO5) and their variants.

Purpose of the Study:

  • To systematically analyze FMO1-FMO5 transcripts in human tissues.
  • To identify and characterize FMO splice variants and assess their functional implications.

Main Methods:

  • Reverse-transcription-polymerase chain reaction (RT-PCR) was used to analyze FMO transcripts across various human tissues.
  • Functional activity of selected FMO variants was assessed using specific substrates (methimazole and a phenothiazine derivative).

Main Results:

  • A significant number of FMO splice variants were identified, with exon skipping being the predominant event.
  • Most splice variants resulted in frame-shifts or loss of functional sites, rendering them non-functional.
  • A common in-frame exon deletion (exon 3 for FMO1, FMO3, FMO5; exon 4 for FMO4) was observed in multiple FMO genes.
  • Exon-deleted FMO variants demonstrated a lack of catalytic activity towards tested substrates.

Conclusions:

  • The expression of FMO genes in human tissues generates numerous splice variants, many of which are non-functional.
  • Common exon-deleted FMO variants, including those in FMO1, FMO3, FMO4, and FMO5, are enzymatically inactive for key substrates.
  • The functional consequences of these splice variants on other potential substrates remain to be elucidated.

Related Experiment Videos